IRIS
VAGO, LUCA ALDO EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.341
AS - Asia 5.180
NA - Nord America 4.014
SA - Sud America 1.565
Continente sconosciuto - Info sul continente non disponibili 319
AF - Africa 118
OC - Oceania 17
Totale 16.554
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.768
RU - Federazione Russa 3.076
SG - Singapore 1.790
CN - Cina 1.571
BR - Brasile 1.299
HK - Hong Kong 754
IT - Italia 688
SE - Svezia 637
VN - Vietnam 570
FR - Francia 267
DE - Germania 203
GB - Regno Unito 107
AR - Argentina 97
CA - Canada 96
BD - Bangladesh 84
IN - India 77
FI - Finlandia 72
NL - Olanda 70
JP - Giappone 61
AT - Austria 57
EC - Ecuador 57
MX - Messico 55
ID - Indonesia 44
ZA - Sudafrica 39
IQ - Iraq 38
CO - Colombia 33
PL - Polonia 31
JM - Giamaica 30
TR - Turchia 30
PK - Pakistan 25
PY - Paraguay 25
ES - Italia 23
IE - Irlanda 19
UZ - Uzbekistan 19
SA - Arabia Saudita 18
AU - Australia 17
CL - Cile 17
TN - Tunisia 17
VE - Venezuela 17
MA - Marocco 16
UA - Ucraina 15
CR - Costa Rica 14
DZ - Algeria 13
HN - Honduras 12
IR - Iran 12
EG - Egitto 11
HU - Ungheria 11
MY - Malesia 11
NI - Nicaragua 11
BE - Belgio 10
KE - Kenya 9
PE - Perù 9
CH - Svizzera 8
LT - Lituania 8
PH - Filippine 8
TT - Trinidad e Tobago 8
GT - Guatemala 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
LB - Libano 6
TW - Taiwan 6
AZ - Azerbaigian 5
IL - Israele 5
JO - Giordania 5
KW - Kuwait 5
KZ - Kazakistan 5
NP - Nepal 5
RS - Serbia 5
SV - El Salvador 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
BO - Bolivia 3
BY - Bielorussia 3
DK - Danimarca 3
GE - Georgia 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BB - Barbados 2
BH - Bahrain 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
GR - Grecia 2
HR - Croazia 2
KR - Corea 2
MD - Moldavia 2
PA - Panama 2
QA - Qatar 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TG - Togo 2
AM - Armenia 1
BG - Bulgaria 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
Totale 16.224
Salva come PNG Salva come JPEG
Città #
Singapore 822
Hong Kong 679
Moscow 654
San Jose 428
Ashburn 410
Dallas 392
Shanghai 334
Council Bluffs 312
Hefei 252
Princeton 226
Lawrence 225
Lauterbourg 223
Ho Chi Minh City 212
Beijing 209
Milan 205
New York 136
São Paulo 128
Hanoi 106
Santa Clara 91
Los Angeles 72
Nuremberg 62
Phoenix 56
Helsinki 43
Omaha 42
Rome 38
Boardman 35
Rio de Janeiro 34
Brooklyn 33
Tokyo 32
Orem 31
Denver 30
Guangzhou 29
Munich 29
Brasília 28
Da Nang 28
Chicago 27
Atlanta 26
Belo Horizonte 26
Montreal 26
Vienna 26
Haiphong 25
Warsaw 24
Houston 23
Johannesburg 23
Quito 22
Cesano Boscone 21
Chennai 20
Guayaquil 20
Stockholm 20
Curitiba 19
Dublin 19
London 18
Poplar 18
Kingston 17
Manchester 17
Mexico City 17
Tianjin 17
Baghdad 16
Seattle 16
Tashkent 16
Turku 16
Washington 16
Frankfurt am Main 15
Shenzhen 15
Toronto 15
Hải Dương 14
Salvador 14
Amsterdam 13
Bergamo 13
Bologna 13
Ankara 12
Campinas 12
Naples 12
Porto Alegre 12
Caxias do Sul 11
Dhaka 11
Hangzhou 11
Lappeenranta 11
Recife 11
San Francisco 11
Turin 11
Baltimore 10
Bolzano 10
Buffalo 10
Chaoyang 10
Charlotte 10
Duque de Caxias 10
Managua 10
Nova Iguaçu 10
Shijiazhuang 10
Brescia 9
Budapest 9
Cleveland 9
Columbus 9
Florence 9
Guarulhos 9
Ninh Bình 9
Queens 9
Reston 9
São Gonçalo 9
Totale 7.634
Salva come PNG Salva come JPEG
Nome #
Loss of mismatched HLA in leukemia after stem-cell transplantation 223
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 188
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 180
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 179
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 173
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 171
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 155
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 150
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 144
TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells 142
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 140
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 134
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 133
NON-GENOMIC ALTERATIONS IN ANTIGEN PRESENTATION AND T CELL COSTIMULATION ARE DISTINCT DRIVERS OF LEUKEMIA IMMUNE ESCAPE AND RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION 124
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 122
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 120
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 118
MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING 118
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 112
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 110
The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia 110
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes 110
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 108
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 107
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 107
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 107
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 106
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse 102
Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy 101
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 100
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma 98
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti 97
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody 97
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 96
Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation 96
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 95
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells 93
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 92
An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 92
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation 89
Anidulafungin primary antifungal prophylaxis in 36 high-risk haematological patients undergoing haematopoietic stem cell transplantation 88
An Accelerated CD8+, but Not CD4+, T -Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 88
Alterations in the genomic and transcriptional profile of leukemia upon the immune pressure of allogenic hematopoietic stem cell transplantation: tracking immunoediting by high-throughput techniques 87
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 87
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 87
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 87
MRD in Venetoclax-Based Treatment for AML: Does it Really Matter? 86
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 86
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 84
AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT 83
Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease 82
Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report 81
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 81
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse 81
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 80
ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES: 4GY TBI TO INTENSIFY TREOSULFAN AND FLUDARABINE-BASED CONDITIONING 80
Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia 80
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 79
Allogeneic haematopoietic stem cell transplantation in patients older than 65 years with high risk acute myeloid leukemia: results in 46 consecutive patients 79
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 78
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party 77
Sorafenib maintenance in FLT3-ITD mutated AML after allogeneic HCT: a real-world, single-center experience 77
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 75
SUICIDE GENE TRANSFER INTO DONOR LYMPHOCYTES ALLOWS EARLY AND EFFECTIVE IMMUNE-RECONSTITUTION AFTER FAMILY HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LEUKEMIAS: RESULTS OF THE TK007 STUDY 75
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 74
TREOSULFAN-BASED CONDITIONING AND UNMANIPULATED PERIPHERAL BLOOD HAPLOIDENTICAL TRANSPLANTATION (HAPLOSCT) FOR PRIMARY REFRACTORY AND RELAPSED AML: RESULTS IN 63 PATIENTS 73
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 73
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 72
The effect of donor-recipient KIR ligand incompatibility after haploidentical hematopoietic stem cell transplantation is overruled by biological characteristics of early reconstituting NK cells with impaired graft versus leukemia activity 72
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 72
Experts' considerations on HLA-haploidentical stem cell transplantation 71
Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation 71
Targeting WT1 reactivation in patients in complete remission after allogeneic haematopoietic stem cell transplantation for AML and MDS: results in 111 patients 71
Time of Origin and Environmental Drivers of Leukemia Immune Escape after Transplantation 70
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors 69
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: Dynamics and clinical implications 68
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells 66
Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation 66
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes 66
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 66
Improving the safety of cell therapy with the TK-suicide gene. 65
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 65
Timing and rate of success in transplant of MUD searches through BMDW: the real case of CIC-813 in 2006–2009 64
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 64
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 64
Tracking genetically engineered lymphocytes long-term reveals the dynamic of T-cell immunological memory 64
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 63
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation 63
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 63
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 63
Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors 63
Mutation at Positively Selected Positions in the Binding Site for HLA-C Shows That KIR2DL1 Is a More Refined but Less Adaptable NK Cell Receptor Than KIR2DL3 63
Quantitative PCR for ins/del polymorphisms is a reliable and sensitive tool for host chimerism analysis after allogeneic hematopoietic stem cell transplantation 62
VORICONAZOLE PROPHYLAXIS OF INVASIVE FUNGAL INFECTION IN HAPLOIDENTICAL ALLOGENIC STEM CELL TRANSPLANTATION 61
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 61
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation 60
DAY-14 LAIP ON BONE MARROW PREDICTS COMPLETE RESPONSE AND DRIVE EARLY SALVAGE CHEMOTHERAPY IN AML: RESULTS OF MULTIPARAMETER FLOW CYTOMETRY AND WT1-RNA QUANTIFICATION 60
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 59
Immune escape and immunotherapy of acute myeloid leukemia 59
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 59
Totale 9.272
Salva come PNG Salva come JPEG
Categoria #
all - tutte 110.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.768
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022144 0 0 0 34 12 8 6 21 22 18 10 13
2022/20231.263 493 293 82 10 43 136 38 79 49 14 17 9
2023/2024670 32 29 61 66 44 87 106 56 12 23 30 124
2024/20253.424 429 66 62 86 89 256 431 390 614 510 240 251
2025/20269.695 740 755 732 1.540 668 266 778 651 2.790 418 197 160
2026/20271.154 319 673 162 0 0 0 0 0 0 0 0 0
Totale 16.554